Skip to main content
logo
Celularity Inc. (CELU)
NASDAQ: CELU · Real-Time Price · USD
0.6830
-0.0512 (-6.97%)
Aug 6, 2026, 4:00 PM EDT - Market closed

Celularity Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-91.72-57.89-196.314.19-100.12
Depreciation & Amortization
7.37.929.329.448.82
Stock-Based Compensation
0.2611.5715.0215.8640.01
Other Adjustments
2.33----
Changes in Other Operating Activities
0----
Operating Cash Flow
-81.82-38.4-171.9539.48-51.29
Operating Cash Flow Growth
-----

Investing Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
16.81----
Net Long-Term Debt Issued (Repaid)
16.81----
Issuance of Common Stock
5.5----
Net Common Stock Issued (Repurchased)
5.5----
Other Financing Activities
-0.04----
Financing Cash Flow
22.27----

Net Cash Flow

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
-59.56-38.4-171.9539.48-51.29

Free Cash Flow

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-81.82-38.4-171.9539.48-51.29
Free Cash Flow Growth
-----
FCF Margin
-308.19%-70.82%-755.14%219.66%-240.41%
Free Cash Flow Per Share
-3.20-1.75-9.652.64-7.65
Levered Free Cash Flow
-159.41-107.86-186.9723.63-91.3
Unlevered Free Cash Flow
-54.01-30.44-182.97-16.14-100.26
SEC Filings: 10-K · 10-Q